|

Exergaming Revolution in Dementia

RECRUITINGN/ASponsored by Eastern Switzerland University of Applied Sciences
Actively Recruiting
PhaseN/A
SponsorEastern Switzerland University of Applied Sciences
Started2024-09-27
Est. completion2027-01-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06631742

Summary

This pilot randomized controlled trial evaluates the effect of a 12 weeks exergaming training in people with major neurocognitive disorders (MNCD) living in long-term care facilities.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Neurocognitive disorder based on Alzheimer's Disease, Parkinson's disease, Lewy body dementia or Mixed dementia according to the criteria of the American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5)
* Mini-Mental-Status-Examination (MMSE) Score of ≥5 and ≤26 out of e maximum of 30

Exclusion Criteria:

* MMSE \<5
* Unstable cardiovascular condition or other medical condition that does not allow for safe participation according to the recommendations of the American College of Sports Medicine
* Planned transfer to another facility within the next 3 months
* Acute behavioural problems

Conditions6

Alzheimer DiseaseAlzheimer's DiseaseLewy Body DementiaMajor Neurocognitive DisorderMixed DementiasParkinson Disease

Browse More Trials

Alzheimer's Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.